TY - JOUR
T1 - Major Adverse Cardiovascular Events in Korean Congenital Heart Disease Patients
T2 - A Nationwide Age-and Sex-Matched Case-Control Study
AU - Lee, Jue Seong
AU - Jung, Jin Man
AU - Choi, Jongun
AU - Seo, Woo Keun
AU - Shin, Hong Ju
N1 - Publisher Copyright:
© Yonsei University College of Medicine 2022.
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Purpose: Congenital heart disease (CHD) is a known risk factor for acquired cardiovascular and cerebrovascular diseases. How-ever, available evidence on CHD is limited mostly to Western populations. This study aimed to evaluate the prevalence of vascular events and all-cause mortality in Korean patients with CHD and to further corroborate CHD as a predictor of vascular events and all-cause mortality. Materials and Methods: The claims data of the Korean National Health Insurance Service (NHIS) were retrospectively reviewed. Information regarding diagnostic codes, comorbidities, medical services, income level, and residential area was also collected. Outcomes of interest included stroke, myocardial infarction (MI), all-cause mortality, and major adverse cardiovascular events (MACE). Results: We included 232203 patients with CHD and 3024633 individuals without CHD as a control group through age-and sex-matched 1:10 random sampling. The prevalences of hypertension, congestive heart failure, ischemic heart disease, hyperlipid-emia, and atrial fibrillation were significantly higher in the CHD group, which had a more than two-fold higher incidence of vascular events and all-cause mortality, than in the group without CHD. Multivariable models demonstrated that CHD was a significant risk factor for stroke, MI, all-cause mortality, and MACE. Conclusion: In conclusion, this nationwide study demonstrates that Korean patients with CHD have a high incidence of comorbidi-ties, vascular events, and mortality. CHD has been established as an important predictor of cardiovascular events. Further studies are warranted to identify high-risk patients with CHD and related factors to prevent vascular events.
AB - Purpose: Congenital heart disease (CHD) is a known risk factor for acquired cardiovascular and cerebrovascular diseases. How-ever, available evidence on CHD is limited mostly to Western populations. This study aimed to evaluate the prevalence of vascular events and all-cause mortality in Korean patients with CHD and to further corroborate CHD as a predictor of vascular events and all-cause mortality. Materials and Methods: The claims data of the Korean National Health Insurance Service (NHIS) were retrospectively reviewed. Information regarding diagnostic codes, comorbidities, medical services, income level, and residential area was also collected. Outcomes of interest included stroke, myocardial infarction (MI), all-cause mortality, and major adverse cardiovascular events (MACE). Results: We included 232203 patients with CHD and 3024633 individuals without CHD as a control group through age-and sex-matched 1:10 random sampling. The prevalences of hypertension, congestive heart failure, ischemic heart disease, hyperlipid-emia, and atrial fibrillation were significantly higher in the CHD group, which had a more than two-fold higher incidence of vascular events and all-cause mortality, than in the group without CHD. Multivariable models demonstrated that CHD was a significant risk factor for stroke, MI, all-cause mortality, and MACE. Conclusion: In conclusion, this nationwide study demonstrates that Korean patients with CHD have a high incidence of comorbidi-ties, vascular events, and mortality. CHD has been established as an important predictor of cardiovascular events. Further studies are warranted to identify high-risk patients with CHD and related factors to prevent vascular events.
KW - all-cause mortality
KW - Congenital heart disease
KW - Korean nationwide study
KW - vascular events
UR - https://www.scopus.com/pages/publications/85142649111
U2 - 10.3349/ymj.2022.0111
DO - 10.3349/ymj.2022.0111
M3 - Article
C2 - 36444542
AN - SCOPUS:85142649111
SN - 0513-5796
VL - 63
SP - 1069
EP - 1077
JO - Yonsei Medical Journal
JF - Yonsei Medical Journal
IS - 12
ER -